X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11465) 11465
animals (10947) 10947
ng-nitroarginine methyl ester - pharmacology (9184) 9184
male (7653) 7653
rats (7048) 7048
nitric oxide (5878) 5878
enzyme inhibitors - pharmacology (5861) 5861
nitric oxide synthase - antagonists & inhibitors (4513) 4513
nitric oxide - metabolism (3026) 3026
arginine - pharmacology (2777) 2777
rats, sprague-dawley (2703) 2703
pharmacology & pharmacy (2678) 2678
rats, wistar (2662) 2662
nitric oxide - physiology (2646) 2646
ng-nitroarginine methyl ester (2459) 2459
female (2307) 2307
in vitro techniques (1975) 1975
physiology (1973) 1973
arginine - analogs & derivatives (1944) 1944
dose-response relationship, drug (1912) 1912
blood pressure - drug effects (1826) 1826
mice (1750) 1750
nitric oxide synthase - metabolism (1705) 1705
nitric-oxide (1694) 1694
humans (1478) 1478
endothelium (1428) 1428
l-arginine (1412) 1412
nitric-oxide synthase (1412) 1412
vasodilation - drug effects (1342) 1342
neurosciences (1300) 1300
nitric oxide - antagonists & inhibitors (1289) 1289
peripheral vascular disease (1266) 1266
inhibition (1262) 1262
synthase (1185) 1185
nitric oxide synthase (1127) 1127
rat (1120) 1120
hypertension (1101) 1101
l-name (1041) 1041
vasodilator agents - pharmacology (1020) 1020
nitric oxide - biosynthesis (1006) 1006
biochemistry & molecular biology (997) 997
endothelium, vascular - drug effects (983) 983
nitroprusside - pharmacology (978) 978
acetylcholine - pharmacology (965) 965
cardiac & cardiovascular systems (944) 944
expression (932) 932
time factors (918) 918
cells (914) 914
indomethacin - pharmacology (848) 848
cells, cultured (838) 838
relaxing factor (838) 838
disease models, animal (826) 826
endothelium, vascular - physiology (759) 759
vasoconstriction - drug effects (742) 742
oxidative stress (722) 722
abridged index medicus (716) 716
muscle, smooth, vascular - drug effects (714) 714
release (710) 710
blood pressure (701) 701
rabbits (698) 698
physiological aspects (695) 695
smooth-muscle (671) 671
rodents (664) 664
acetylcholine (659) 659
nitric oxide donors - pharmacology (652) 652
activation (622) 622
relaxation (610) 610
vasodilation (604) 604
cell biology (591) 591
vasoconstrictor agents - pharmacology (587) 587
in-vivo (584) 584
blood-pressure (579) 579
endothelial-cells (550) 550
medicine, research & experimental (543) 543
heart rate - drug effects (542) 542
vasodilation - physiology (541) 541
endothelium, vascular - metabolism (539) 539
muscle contraction - drug effects (538) 538
nitric oxide - pharmacology (534) 534
nitric oxide synthase type iii (529) 529
blood-flow (524) 524
brain (523) 523
hypertension - physiopathology (517) 517
arginine (508) 508
dogs (506) 506
mechanisms (501) 501
responses (492) 492
cyclic gmp - metabolism (491) 491
electric stimulation (489) 489
phenylephrine - pharmacology (485) 485
endocrinology & metabolism (480) 480
hemodynamics - drug effects (472) 472
nitric oxide synthase type ii (454) 454
research (453) 453
cyclooxygenase inhibitors - pharmacology (449) 449
blood pressure - physiology (447) 447
mice, inbred c57bl (447) 447
in-vitro (444) 444
muscle relaxation - drug effects (444) 444
analysis of variance (436) 436
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11679) 11679
Chinese (82) 82
Russian (66) 66
Japanese (23) 23
Ukrainian (15) 15
French (13) 13
Spanish (8) 8
Czech (3) 3
German (3) 3
Hungarian (2) 2
Polish (2) 2
Portuguese (2) 2
Romanian (2) 2
Slovak (2) 2
Korean (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Cancer, ISSN 0020-7136, 08/2014, Volume 135, Issue 4, pp. 774 - 784
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 03/2016, Volume 310, Issue 6, pp. H667 - H680
Mitochondrial dysfunction has been implicated as a cause of energy deprivation in heart failure (HF). Herein, we tested individual and combined effects of two... 
heart failure | nitric oxide | angiotensin II | mitochondria | oxidative stress | Mitochondria, Heart - metabolism | Gene Expression - drug effects | DNA, Mitochondrial - drug effects | Mitochondria, Heart - drug effects | Calcium-Calmodulin-Dependent Protein Kinase Type 2 - drug effects | Electron Transport Complex I - metabolism | Sarcoplasmic Reticulum Calcium-Transporting ATPases - drug effects | Cardiomegaly | Myocardium - metabolism | Natriuretic Peptide, C-Type - drug effects | Heart Failure - etiology | Pyruvate Dehydrogenase Complex - drug effects | NG-Nitroarginine Methyl Ester - pharmacology | Pyruvate Dehydrogenase Complex - metabolism | Vasoconstrictor Agents - pharmacology | Angiotensin II - pharmacology | Natriuretic Peptide, Brain - genetics | Protein Precursors - genetics | DNA, Mitochondrial - metabolism | Enzyme Inhibitors - pharmacology | Myocardium - pathology | Reverse Transcriptase Polymerase Chain Reaction | Electron Transport Complex I - drug effects | Hydrogen Peroxide - metabolism | Calcium-Calmodulin-Dependent Protein Kinase Type 2 - genetics | Animals | Protein Precursors - drug effects | Electron Transport Complex II - metabolism | Natriuretic Peptide, Brain - drug effects | Heart - drug effects | Natriuretic Peptide, C-Type - genetics | Mice | Oxidative Stress - drug effects | Electron Transport Complex II - drug effects | Nitric Oxide - metabolism | Sarcoplasmic Reticulum Calcium-Transporting ATPases - genetics | Index Medicus
Journal Article
Science, ISSN 0036-8075, 10/2003, Volume 302, Issue 5642, pp. 100 - 103
Nitric oxide (NO) serves as a signal in plants. An Arabidopsis mutant (AtNOS1) was identified that had impaired NO production, organ growth, and abscisic... 
Enzymes | Dyes | Plant growth | Plant growth regulators | Plant roots | Oxides | Stomata | Reports | Standard deviation | Plants | Seedlings | GUARD-CELLS | GENERATION | PROTEIN | ABSCISIC-ACID | MULTIDISCIPLINARY SCIENCES | STOMATAL CLOSURE | Plant Shoots - growth & development | Nitric Oxide Synthase - chemistry | Arabidopsis - enzymology | Arabidopsis - growth & development | Genes, Plant | Molecular Sequence Data | Nitroprusside - pharmacology | Nitric Oxide Synthase - genetics | Arabidopsis Proteins - metabolism | Light | Nitric Oxide Donors - pharmacology | Plant Leaves - enzymology | Plant Roots - growth & development | NG-Nitroarginine Methyl Ester - pharmacology | Plant Epidermis - physiology | Amino Acid Sequence | Arabidopsis Proteins - genetics | Signal Transduction | Enzyme Inhibitors - pharmacology | Plant Epidermis - drug effects | Arabidopsis - genetics | Arabidopsis Proteins - isolation & purification | Abscisic Acid - pharmacology | Arabidopsis Proteins - chemistry | Plant Leaves - growth & development | Nitric Oxide Synthase - isolation & purification | Nitric Oxide Synthase - metabolism | Kinetics | Mutation | Nitric Oxide - metabolism | Plant Leaves - physiology | Physiological aspects | Research | Arabidopsis | Nitric oxide | Botany | Signaling | Flowers & plants | Hormones | Genes | Index Medicus
Journal Article
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 03/2011, Volume 300, Issue 3, pp. H792 - H802
Pankey EA, Bhartiya M, Badejo AM, Jr, Haider U, Stasch J, Murthy SN, Nossaman BD, Kadowitz PJ. Pulmonary and systemic vasodilator responses to the soluble... 
4-({(4-carboxybutyl)[2- (5-fluoro-2-{[4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl) ethyl]amino}methyl)benzoic acid | Pulmonary and systemic vascular beds | Sodium nitroprusside | 2-{1-[2-(fluorophenyl)methyl]-1Hpyrazolo[ 3,4-b]pyridin-3-yl}-5(4-morpholinyl)-4,6-pyrimidinediamine | Guanylyl cyclase/activator/stimulator/inhibitor | U-46619 | Monocrotaline | 1H-[1,2,4]-oxadizaolo[4,3]quinoxaline-1-one | nitro-L-arginine methyl ester hydrochloride | Nitric oxide/synthase/donor | Pulmonary hypertension | STIMULATOR | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | pulmonary hypertension | guanylyl cyclase/activator/stimulator/inhibitor | 4-({(4-carboxybutyl)[2-(5-fluoro-2-{[4 '-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl) ethyl]amino}methyl)benzoic acid | monocrotaline | RELAXING FACTOR | CINACIGUAT | nitric oxide/synthase/donor | N-omega-nitro-L-arginine methyl ester hydrochloride 1H-[1,2,4]-oxadizaolo[4,3]quinoxaline-1-one | INHIBITION | sodium nitroprusside | BOVINE LUNG | pulmonary and systemic vascular beds | PERIPHERAL VASCULAR DISEASE | DECOMPENSATED HEART-FAILURE | INDEPENDENT ACTIVATION | ARTERY | MOLECULAR-BASIS | ODQ | 2-{1-[2-(fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl}-5(4-morpholinyl)-4,6-pyrimidinediamine | NG-Nitroarginine Methyl Ester - pharmacology | Vasoconstrictor Agents - pharmacology | Vasodilator Agents - pharmacology | Nitric Oxide - pharmacology | Hydrocarbons, Fluorinated - pharmacology | Monocrotaline - pharmacology | Rats | Guanylate Cyclase - metabolism | Male | Nitroprusside - pharmacology | Biphenyl Compounds | Rats, Sprague-Dawley | Quinoxalines - pharmacology | Heme - pharmacology | Animals | Oxadiazoles - pharmacology | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid - pharmacology | Benzoates - pharmacology | Hypertension, Pulmonary - drug therapy | Vasodilation - drug effects | Nitric Oxide - metabolism | Vasodilators | Nitric oxide | Dosage and administration | Research | Guanylate cyclase | Health aspects | Respiratory physiology | Studies | Enzymes | Sodium | Pulmonary arteries | Enzyme kinetics | Cells | Index Medicus | Vascular Biology and Microcirculation | nitric oxide | Nω-nitro-l-arginine methyl ester hydrochloride | guanylyl cyclase | donor | inhibitor | synthase | activator | stimulator | 4-({(4-carboxybutyl)[2-(5-fluoro-2-{[4′-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]amino}methyl)benzoic acid
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 09/2010, Volume 120, Issue 9, pp. 3350 - 3364
Journal Article
Cancer Cell, ISSN 1535-6108, 04/2016, Volume 29, Issue 4, pp. 587 - 601
The immune response influences the clinical course of colorectal cancer (CRC). Analyzing the invasive margin of human CRC liver metastases, we identified a... 
BREAST-CANCER | HEPATOCELLULAR-CARCINOMA | ANTAGONIST | ONCOLOGY | MIGRATION INHIBITORY FACTOR | IMMUNOTHERAPY | INFLAMMATION | QUANTIFICATION | CHEMOKINE RECEPTOR CCR5 | CHEMOTHERAPY | PROGRESSION | CELL BIOLOGY | Liver Neoplasms - secretion | Lung Neoplasms - drug therapy | Clodronic Acid - pharmacology | Apoptosis - drug effects | Cyclohexanes - pharmacology | Humans | Neoplasm Proteins - physiology | Neoplasm Proteins - antagonists & inhibitors | Molecular Targeted Therapy | Chemokine CCL5 - secretion | Chemokine CCL5 - antagonists & inhibitors | Cyclohexanes - therapeutic use | Macrophages - secretion | Receptors, CCR5 - metabolism | STAT3 Transcription Factor - physiology | Lung Neoplasms - secondary | Tumor Cells, Cultured | Liver Neoplasms - secondary | Pyridines - therapeutic use | Triazoles - therapeutic use | NG-Nitroarginine Methyl Ester - pharmacology | Tumor Microenvironment - drug effects | Neoplasm Invasiveness | Adenocarcinoma - immunology | Liver Neoplasms - drug therapy | Chemokines - physiology | Phenylurea Compounds - therapeutic use | Receptors, CCR5 - drug effects | Liver Neoplasms - immunology | Adenocarcinoma - drug therapy | Chemotaxis | Adenocarcinoma - secondary | Triazoles - pharmacology | Pilot Projects | Chemokine CCL5 - biosynthesis | Colorectal Neoplasms - immunology | Interferon-alpha - secretion | Survival Analysis | Macrophages - drug effects | Lymphocytes, Tumor-Infiltrating - secretion | Clinical Trials, Phase I as Topic | Lymphocytes, Tumor-Infiltrating - immunology | Care and treatment | Liver | Colorectal cancer | Metastasis | T cells | Health aspects | Cancer | Macrophages | Index Medicus
Journal Article